Skip to content

The evaluation of aphakic iris claw intraocular lens implantation results

Outcomes of primary iris claw intraocular lens implantation for correction aphakia in comparison with scleral fixation intraocular lens implantation during pars plana deep vitrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201103116032N1
Enrollment
25
Registered
2011-06-01
Start date
2009-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphakia.

Interventions

The ARTISAN aphakia IOL is a polymethyl methacrylate IOL with an 8.5-mm length, and a 5.5-mm optical zone. In one group patients, initialy a standard 3-port Pars Plana vitrectomy were performed. Cryst
Treatment - Surgery

Sponsors

Ahwaz Jondishapour University Of Medicine Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Dislocation of total crystalline lens v/s fragment of nucleus v/s IOL in vitreous after complicated cataract surgery or due to trauma, Absence of capsular support for IOL implantation in capsular bag or ciliary sulcus Exclusion criteria: Uncontrolled glaucoma, recurrent uveitis history, severe iris damage, proliferative diabetic retinopathy, macular scar

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Uncorrected visual acuity (UCVA). Timepoint: one day preoperatively and the first day, third day, at the end of the first. Method of measurement: visual acuity without correction based on snellen chart at 6 meter.;Best corrected visual acuity (BCVA). Timepoint: one day preoperatively and the first day, third day, at the end of the first. Method of measurement: visual acuity based on snellen chart at 6 meter,after correction.(based on subjective refraction.;Central corneal thickness (CCT). Timepoint: one day preoperatively and the first day, third day, at the end of the first. Method of measurement: central corneal thickness (micron) based on Pachymetry.;Spherical equivalent (SE). Timepoint: one day preoperatively and the first day, third day, at the end of the first. Method of measurement: spherical power (diopter) based on objective refraction.: S.E =Sphere+Cylinder/2.;Astigmatism. Timepoint: one day preoperatively and the first day, third day, at the end of the first. Method of measurement: cylinder power based on objective refraction.

Secondary

MeasureTime frame
Cystoid macular edema (complication). Timepoint: one day preoperatively and the first day, third day, at the end of the first. Method of measurement: Edema in macular zone based on fundus examination.(confirmed by OCT).;Intra ocular pressure(IOP) increase (complication). Timepoint: one day preoperatively and the first day, third day, at the end of the first. Method of measurement: IOP> 22 mmHg (Based on Goldmann Tonometer).;Retinal Detachment (complication). Timepoint: one day preoperatively and the first day, third day, at the end of the first. Method of measurement: Based on fundus examination.;Lens haptic displacement (complication). Timepoint: one day preoperatively and the first day, third day, at the end of the first. Method of measurement: Based on Slit Lamp examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Afkari

Imam Khomeini Hospital

abafkari@yahoo.com+98 61 1222 8076

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026